Point-of-Care Test Measures Response to Clopidogrel


December 30, 2009

The T-Guide diagnostic test assesses patient response to clopidogrel to screen for the 30 percent of patients who do not respond to the anti-platelet drug. The simple, inexpensive, disposable test kit is designed for point-of-care use. It enables nontechnical staff to run the tests in physicians' offices and clinics.

For more information: www.thrombovision.com

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.